Home/Filings/4/0001209191-22-036400
4//SEC Filing

Marrone Pamela G 4

Accession 0001209191-22-036400

CIK 0001441693other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 5:20 PM ET

Size

6.2 KB

Accession

0001209191-22-036400

Insider Transaction Report

Form 4
Period: 2022-06-09
Marrone Pamela G
DirectorCEO and President
Transactions
  • Sale

    Common Stock

    2022-06-09$1.18/sh20,492$24,1212,179,134 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    6,442
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.15 to $1.21, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F3]Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

Entity typeother

Related Parties

1
  • filerCIK 0001582885

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:20 PM ET
Size
6.2 KB